Filing Details
- Accession Number:
- 0001171843-15-005929
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-03 16:40:02
- Reporting Period:
- 2015-11-02
- Filing Date:
- 2015-11-03
- Accepted Time:
- 2015-11-03 16:40:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1359931 | Proteon Therapeutics Inc | PRTO | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185035 | P Timothy Noyes | C/O Proteon Therapeutics 200 West Street Waltham MA 02451 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-02 | 5,000 | $1.91 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-02 | 5,000 | $13.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Stock Option (Right to Buy) | Disposition | 2015-11-02 | 5,000 | $0.00 | 5,000 | $1.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 68,742 | 2016-04-19 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015.
- All shares were sold at a price of $13.50 per share.
- The option was granted on April 19, 2006. All shares underlying the option have vested.
Billionaire Hedge Funds
